HY-P2468-1mg
|
MedChemexpress LLC
|
BAD (103-127) (human) [CAS 331762-68-6]
|
|
Cancer-programmed cell death
|
|
HY-P2468-10mg
|
MedChemexpress LLC
|
BAD (103-127) (human) [CAS 331762-68-6]
|
|
Cancer-programmed cell death
|
|
HY-P2468-5mg
|
MedChemexpress LLC
|
BAD (103-127) (human) [CAS 331762-68-6]
|
|
Cancer-programmed cell death
|
|
HY-106934A-10mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
HY-106934A-100mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
HY-106934A-5mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
HY-106934A-50mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
HY-106934A-1mL
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
HY-106934-10mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
HY-106934-100mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
HY-106934-5mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
HY-106934-50mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
HY-106934-1mL
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
HY-101454-10mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
HY-101454-100mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
HY-101454-25mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
HY-101454-5mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
HY-101454-50mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
HY-101454-1mL
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-141716-10mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
HY-141716-100mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
HY-141716-25mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
HY-141716-5mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
HY-141716-50mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
HY-107615-10mg
|
MedChemexpress LLC
|
TC LPA5 4 [CAS 1393814-38-4]
|
|
Cancer-programmed cell death
|
|